NEVVI Medicare utilization intelligence

← back

MOORE, HARRYM.D. NPI 1699096388 Clinician

Hematology-Oncology · MACON, GA

Specialty Hematology-Oncology — from billed Medicare claims
Trained MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 28 years since medical school (class of 1998, self-reported to CMS)
Location MACON, GA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 95 codes billed · 239,437 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
AMERICAN ONCOLOGY PARTNERS PA
2025–2026
CENTRAL GEORGIA CANCER CARE, P.C.
2019–2025

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2026-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J9025 Injection, azacitidine, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9299 Injection, nivolumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0897 Injection, denosumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0185 Injection, aprepitant, 1 mg
J9119 Injection, cemiplimab-rwlc, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J9173 Injection, durvalumab, 10 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J9171 Injection, docetaxel, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
80053 Blood test, comprehensive group of blood chemicals
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
J0461 Injection, atropine sulfate, 0.01 mg
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82728 Ferritin (blood protein) level
J2405 Injection, ondansetron hydrochloride, per 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J9206 Injection, irinotecan, 20 mg
J9181 Injection, etoposide, 10 mg
83540 Iron level
36415 Insertion of needle into vein for collection of blood sample
96372 Injection of drug or substance under skin or into muscle
J9045 Injection, carboplatin, 50 mg
J3480 Injection, potassium chloride, per 2 meq
83550 Iron binding capacity
96375 Injection of additional new drug or substance into vein
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
82607 Cyanocobalamin (vitamin b-12) level
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
83615 Lactate dehydrogenase (enzyme) level
82746 Folic acid level, serum
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
84443 Blood test, thyroid stimulating hormone (tsh)
J9060 Injection, cisplatin, powder or solution, 10 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
83735 Magnesium level
J9000 Injection, doxorubicin hydrochloride, 10 mg
J3489 Injection, zoledronic acid, 1 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3475 Injection, magnesium sulfate, per 500 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96523 Irrigation of implanted venous access drug delivery device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
82784 Gammaglobulin (immune system protein) measurement
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
82565 Blood creatinine level
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96411 Administration of additional new drug or substance into vein using push technique
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
83521 Measurement of immunoglobulin light chains
71260 Ct scan of chest with contrast
96361 Infusion into a vein for hydration, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
74177 Ct scan of abdomen and pelvis with contrast
82378 Carcinoembryonic antigen (cea) protein level
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J7030 Infusion, normal saline solution , 1000 cc
96360 Infusion into a vein for hydration, 31-60 minutes
83010 Haptoglobin (serum protein) level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
84100 Phosphate level
J2997 Injection, alteplase recombinant, 1 mg
84550 Uric acid level, blood
81003 Automated urinalysis test
83883 Nephelometry, test method using light
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J1940 Injection, furosemide, up to 20 mg
71250 Ct scan of chest without contrast
81002 Urinalysis, manual test
96409 Administration of chemotherapy into vein using push technique
84439 Thyroxine (thyroid chemical), free
74176 Ct scan of abdomen and pelvis without contrast
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.